$BIVI
BIOVIE INC. Stock $bivi

$bivi Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000152013822000502 Filed on November 04, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$4.405M	$2.007M	$2.644M
YoY Change	118.46%	-24.1%	1049.72%
% of Gross Profit
Research & Development	$7.033M	$6.770M	$2.846M
YoY Change	53.17%	137.91%	2745.59%
% of Gross Profit
Depreciation & Amortization	$57.35K	$57.34K	$57.34K
YoY Change	0.0%	0.0%	-4.43%
% of Gross Profit
Operating Expenses	$11.49M	$8.834M	$5.547M
YoY Change	72.46%	59.26%	1322.38%
Operating Profit	-$11.49M	-$8.834M	-$5.547M
YoY Change	72.46%	59.26%
Interest Expense	$1.053M	$1.056M	$6.540K
YoY Change	-15.77%	16053.15%	-99.92%
% of Operating Profit
Other Income/Expense, Net	-$4.192M
YoY Change
Pretax Income	-$15.69M	-$10.42M	-$5.541M
YoY Change	189.73%	87.98%	-175.59%
Income Tax
% Of Pretax Income
Net Earnings	-$15.69M	-$10.42M	-$5.541M
YoY Change	189.73%	87.98%	-175.59%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.50	-$0.38	-$0.23
Diluted Earnings Per Share	-$0.50	-$0.38	-$233.6K
COMMON SHARES
Basic Shares Outstanding	30.53M shares	30.17M shares	23.72M shares
Diluted Shares Outstanding	31.17M shares	27.21M shares	23.72M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$45.75M	$21.23M	$20.49M
YoY Change	50.53%	3.63%	55.21%
Cash & Equivalents	$45.75M	$21.23M	$20.49M
Short-Term Investments
Other Short-Term Assets	$241.3K	$359.1K	$105.9K
YoY Change	55.8%	239.05%	111.84%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$45.99M	$21.59M	$20.59M
YoY Change	50.56%	4.84%	55.43%
LONG-TERM ASSETS
Property, Plant & Equipment	$100.0K	$109.3K
YoY Change
Goodwill	$345.7K	$345.7K
YoY Change
Intangibles	$751.8K	$809.1K
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.562K	$4.562K
YoY Change
Total Long-Term Assets	$1.202M	$1.269M	$1.384M
YoY Change	-9.4%	-8.35%	-14.02%
TOTAL ASSETS
Total Short-Term Assets	$45.99M	$21.59M	$20.59M
Total Long-Term Assets	$1.202M	$1.269M	$1.384M
Total Assets	$47.19M	$22.86M	$21.98M
YoY Change	48.06%	4.01%	47.9%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.245M	$2.622M	$679.4K
YoY Change	95.14%	285.98%	239.7%
Accrued Expenses	$41.79K	$40.32K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.797M	$4.096M	$1.260M
YoY Change	78.89%	225.04%	530.01%
LONG-TERM LIABILITIES
Long-Term Debt	$13.26M	$12.73M	$0.00
YoY Change	19.35%		-100.0%
Other Long-Term Liabilities			$483.9K
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$483.9K
YoY Change	-100.0%	-100.0%	706.42%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.797M	$4.096M	$1.260M
Total Long-Term Liabilities	$0.00	$0.00	$483.9K
Total Liabilities	$21.12M	$16.90M	$1.744M
YoY Change	33.63%	868.98%	545.88%
SHAREHOLDERS EQUITY
Retained Earnings	-$277.1M	-$261.4M
YoY Change
Common Stock	$303.1M	$267.3M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$26.07M	$5.961M	$20.23M
YoY Change
Total Liabilities & Shareholders Equity	$47.19M	$22.86M	$21.98M
YoY Change	48.06%	4.01%	47.9%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$15.69M	-$10.42M	-$5.541M
YoY Change	189.73%	87.98%	-175.59%
Depreciation, Depletion And Amortization	$57.35K	$57.34K	$57.34K
YoY Change	0.0%	0.0%	-4.43%
Cash From Operating Activities	-$8.009M	-$9.220M	-$2.535M
YoY Change	70.18%	263.77%	134.69%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$18.51M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	32.53M	$11.81M	18.51M
YoY Change	122.64%	-36.2%	29.99%
NET CHANGE
Cash From Operating Activities	-8.009M	-$9.220M	-2.535M
Cash From Investing Activities
Cash From Financing Activities	32.53M	$11.81M	18.51M
Net Change In Cash	24.52M	$2.589M	15.98M
YoY Change	147.56%	-83.79%	21.4%
FREE CASH FLOW
Cash From Operating Activities	-$8.009M	-$9.220M	-$2.535M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001580149
CY2022Q3	dei	Amendment Flag AmendmentFlag	false
CY2022Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2021Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
CY2021Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
CY2021Q3	bivi	Interest Expense From Convertible Debenture InterestExpenseFromConvertibleDebenture		usd
CY2021Q3	bivi	Accretion Of Loan Premium AccretionOfLoanPremium		usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
CY2021Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet		usd
CY2021Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2021Q3	bivi	Net Proceeds From Issuance Of Common Stock Related Party NetProceedsFromIssuanceOfCommonStockRelatedParty		usd
CY2022Q3	dei	Document Type DocumentType	10-Q
CY2022Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q3	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
CY2022Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q3	dei	Entity File Number EntityFileNumber	001-39015
CY2022Q3	dei	Entity Registrant Name EntityRegistrantName	BIOVIE INC.
CY2022Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2510769
CY2022Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	680 W Nye Lane Suite 204
CY2022Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Carson City
CY2022Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	NV
CY2022Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	89703
CY2022Q3	dei	City Area Code CityAreaCode	775
CY2022Q3	dei	Local Phone Number LocalPhoneNumber	888-3162
CY2022Q3	dei	Security12b Title Security12bTitle	Class A Common Stock, par value $0.0001 per share
CY2022Q3	dei	Trading Symbol TradingSymbol	BIVI
CY2022Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2022Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q3	dei	Entity Shell Company EntityShellCompany	false
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	5960923	usd
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	30532830	shares
CY2022Q3	us-gaap	Cash Cash	21230918	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22858713	usd
CY2022Q2	us-gaap	Cash Cash	18641716	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	359123	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4562	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	1268672	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1334999	usd
CY2022Q3	us-gaap	Assets Assets	22858713	usd
CY2022Q2	us-gaap	Assets Assets	20114594	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	2622334	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	2442804	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	483854	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1304925	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	40317	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38884	usd
CY2022Q3	bivi	Warrant Liabilities WarrantLiabilities	442592	usd
CY2022Q2	bivi	Warrant Liabilities WarrantLiabilities	194531	usd
CY2022Q3	bivi	Embedded Derivative Liability EmbeddedDerivativeLiability	506511	usd
CY2022Q2	bivi	Embedded Derivative Liability EmbeddedDerivativeLiability	188030	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4095608	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	4169174	usd
CY2022Q2	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	48385	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	76768	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87414	usd
CY2022Q3	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	2274586	usd
CY2022Q2	bivi	Unearned Premium And Discount UnearnedPremiumAndDiscount	2861314	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	12725414	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	12138686	usd
CY2022Q3	us-gaap	Liabilities Liabilities	16897790	usd
CY2022Q2	us-gaap	Liabilities Liabilities	16443659	usd
CY2022Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	30165319	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	30165319	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24984083	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24984083	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	3015	usd
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	2496	usd
CY2022Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	267343509	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	137879	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	21590041	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	18779595	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	109271	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118254	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	809128	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	866472	usd
CY2022Q3	us-gaap	Goodwill Goodwill	345711	usd
CY2022Q2	us-gaap	Goodwill Goodwill	345711	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4562	usd
CY2022Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	254638329	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-261385601	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250969890	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20114594	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6769932	usd
CY2021Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3094778	usd
CY2022Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2007062	usd
CY2021Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	2395162	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	8834338	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	5547284	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-8834338	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-5547284	usd
CY2022Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-566542	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	1056416	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	1114	usd
CY2022Q3	us-gaap	Interest Income Other InterestIncomeOther	41585	usd
CY2021Q3	us-gaap	Interest Income Other InterestIncomeOther	7645	usd
CY2022Q3	bivi	Total Other Expense Income TotalOtherExpenseIncome	1581373	usd
CY2021Q3	bivi	Total Other Expense Income TotalOtherExpenseIncome	-6531	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-10415711	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-5540753	usd
CY2022Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-10415711	usd
CY2021Q3	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-5540753	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.38
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.38
CY2021Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27212445	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23719927	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27212445	shares
CY2021Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23719927	shares
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-10415711	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-5540753	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q3	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	17537	usd
CY2021Q3	bivi	Stock Based Compensation Restricted Stock StockBasedCompensationRestrictedStock	286759	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	878640	usd
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1926962	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	42554	usd
CY2022Q3	bivi	Interest Expense From Convertible Debenture InterestExpenseFromConvertibleDebenture	-400361	usd
CY2022Q3	bivi	Accretion Of Loan Premium AccretionOfLoanPremium	143813	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	8983	usd
CY2022Q3	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-566542	usd
CY2022Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	221244	usd
CY2021Q3	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	12436	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	179530	usd
CY2021Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-316981	usd
CY2022Q3	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-9213	usd
CY2022Q3	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-869456	usd
CY2021Q3	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	1064479	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-9220320	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2534626	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5903682	usd
CY2021Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18511009	usd
CY2022Q3	bivi	Net Proceeds From Issuance Of Common Stock Related Party NetProceedsFromIssuanceOfCommonStockRelatedParty	5905840	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	11809522	usd
CY2021Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18511009	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	2589202	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	15976383	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18641716	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4511642	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	21230918	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20488025	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	469687	usd
CY2021Q3	us-gaap	Interest Paid Net InterestPaidNet	1114	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	5050315	usd
CY2021Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	2224992	usd
CY2021Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18511009	usd
CY2021Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	286759	shares
CY2021Q3	us-gaap	Share Based Compensation ShareBasedCompensation	1926962	usd
CY2021Q3	us-gaap	Profit Loss ProfitLoss	-5540753	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	20234292	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3670935	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	878640	usd
CY2022Q3	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	17537	shares
CY2022Q3	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	368370	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5903682	usd
CY2022Q3	bivi	Payment For Issuance Of Related Party PaymentForIssuanceOfRelatedParty	94160	usd
CY2022Q3	bivi	Proceeds From Issuance Of Common Stock Net Of Costs Of94160 Related Party ProceedsFromIssuanceOfCommonStockNetOfCostsOf94160RelatedParty	5905840	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-10415711	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	5960923	usd
CY2022Q3	bivi	Working Capital WorkingCapital	17500000	usd
CY2022Q3	us-gaap	Cash Cash	21230918	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	5960923	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-261385601	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1427298	usd
CY2021Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	1484642	usd
CY2022Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11127524	shares
CY2021Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	2206671	shares
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2293770	usd
CY2022Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P10Y
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	809128	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	866472	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	57344	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Rolling Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextRollingTwelveMonths	172033	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Two FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearTwo	229377	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Three FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearThree	229377	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Amortization Expense Rolling Year Four FiniteLivedIntangibleAssetsAmortizationExpenseRollingYearFour	178341	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	809128	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	483854	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1304925	usd
CY2022Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	1161000	usd
CY2022Q3	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	1400000	usd
CY2022Q3	bivi	Fair Value Of Embedded Conversion Option FairValueOfEmbeddedConversionOption	2200000	usd
CY2022Q3	bivi	Direct Financing Cost DirectFinancingCost	390000	usd
CY2022Q3	us-gaap	Debt Instrument Unamortized Premium DebtInstrumentUnamortizedPremium	850000	usd
CY2022Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1100000	usd
CY2022Q3	us-gaap	Debt Instrument Periodic Payment Interest DebtInstrumentPeriodicPaymentInterest	470000	usd
CY2022Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	43000	usd
CY2022Q3	bivi	Unearned Discount UnearnedDiscount	400000	usd
CY2022Q3	us-gaap	Accretion Expense AccretionExpense	144000	usd
CY2022Q3	us-gaap	Notes Payable NotesPayable	15000000	usd
CY2022Q3	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	2335441	usd
CY2022Q2	us-gaap	Deferred Discounts Finance Charges And Interest Included In Receivables DeferredDiscountsFinanceChargesAndInterestIncludedInReceivables	2735802	usd
CY2022Q2	us-gaap	Notes Payable NotesPayable	15000000	usd
CY2022Q3	bivi	Debt Financing Costs DebtFinancingCosts	-248236	usd
CY2022Q2	bivi	Debt Financing Costs DebtFinancingCosts	-290790	usd
CY2022Q3	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	309091	usd
CY2022Q2	bivi	Accretion Of Loan Premiums AccretionOfLoanPremiums	165278	usd
CY2022Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	12725414	usd
CY2022Q2	us-gaap	Long Term Notes Payable LongTermNotesPayable	12138686	usd
CY2022Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	949103	usd
CY2022Q2	us-gaap	Derivative Liabilities DerivativeLiabilities	382561	usd
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3348330	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1113341	shares
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	12800	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	25400	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	109271	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	118254	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	40317	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	38884	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	76768	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	87414	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	117085	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	126298	usd
CY2022Q3	bivi	Schedule Of Future Estimated Minimum Lease Payments Under Non Cancelable Operating Leases ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases	<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfFutureEstimatedMinimumLeasePaymentsUnderNonCancelableOperatingLeases_zrYocrchlIob" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Leases (Details 1)"> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt"><span id="xdx_8BD_zeUu1o99Xazg" style="display: none">Schedule of future estimated minimum lease payments under non-cancelable operating leases</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_497_20220930_zVuuXOeis1d6" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-indent: 0pt; padding-left: 0pt">Year ending June 30, 2023 (Remaining 9 months)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">38,075</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">2024</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,156</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearThree_iI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0pt; padding-left: 0pt">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">44,636</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iI_pp0p0" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Total minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">134,867</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_ecustom--CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayment_iNI_pp0p0" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0pt; padding-left: 0pt">Less amount representing interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(17,782</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--OperatingLeaseLiability_iI_pp0p0_zxVQKWXSwpR3" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 0pt; padding-left: 0pt">Present value of future minimum lease payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">117,085</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiabilityCurrent_iNI_pp0p0_di_zYKSmlm7iKlj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: 0pt; padding-left: 0pt">Less current portion of operating lease liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,317</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_403_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_zAVdVG4tFTq" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 3.5pt; text-indent: 0pt; padding-left: 0pt">Operating lease liabilities, net of current portion</td><td style="padding-bottom: 3.5pt"> </td> <td style="border-bottom: Black 3.5pt double; text-align: left">$</td><td style="border-bottom: Black 3.5pt double; text-align: right">76,768</td><td style="padding-bottom: 3.5pt; text-align: left"> </td></tr> </table>
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	38075	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	52156	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	44636	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	134867	usd
CY2022Q3	bivi	Capital Leases Future Minimum Payments Interest Included In Payment CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayment	-17782	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	117085	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	40317	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	76768	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y9M18D
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.1075	pure
CY2022Q3	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	45479	usd
CY2021Q3	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	23613	usd

Files In Submission

Name	View Source	Status
bivi-20220930_cal.xml	Edgar Link	unprocessable
0001520138-22-000502-index-headers.html	Edgar Link	pending
0001520138-22-000502-index.html	Edgar Link	pending
0001520138-22-000502.txt	Edgar Link	pending
0001520138-22-000502-xbrl.zip	Edgar Link	pending
bivi-20220930.xsd	Edgar Link	pending
bivi-20220930_10q.htm	Edgar Link	pending
bivi-20220930_10qex10z2.htm	Edgar Link	pending
bivi-20220930_10qex31z1.htm	Edgar Link	pending
bivi-20220930_10qex31z2.htm	Edgar Link	pending
bivi-20220930_10qex32z1.htm	Edgar Link	pending
bivi-20220930_10qex32z2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
bivi-20220930_def.xml	Edgar Link	unprocessable
bivi-20220930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bivi-20220930_lab.xml	Edgar Link	unprocessable
bivi-20220930_10q_htm.xml	Edgar Link	completed
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BIVI
BIOVIE INC. Stock $bivi

2022 Q4 Form 10-Q Financial Statement

#000152013822000502 Filed on November 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI BIOVIE INC. Stock $bivi

2022 Q4 Form 10-Q Financial Statement

#000152013822000502 Filed on November 04, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BIVI
BIOVIE INC. Stock $bivi